The Canadian government on Thursday announced the country would donate five million doses of H1N1 vaccines to the WHO from the country’s current surplus, the Canadian Press reports (Branswell, 1/28). “[T]he donation will help the Geneva-based international body in its efforts to redistribute the vaccine to developing countries that couldn’t afford their own supplies,” the Globe and Mail reports (Alphonso, 1/28).
During the WHO’s recent executive board meeting, WHO Director-General Margaret Chan reflected on public health gains over the past decade and the challenges that lie ahead, Nigeria’s Guardian reports. Chan commended the international community’s response to H1N1 and global efforts to reduce child mortality, fight malaria and tuberculosis.
WHO spokesperson Gregory Hartl on Monday rejected accusations that the organization miscategorized H1N1 (swine flu) as a pandemic, calling such accusations “irresponsible,” the Associated Press/Washington Post reports. “WHO also dismissed claims it colluded with drug companies to bring economic benefit to the industry by playing up the danger of the new H1N1 [swine flu] influenza strain,” the news service writes.
Long-Term Rebuilding Strategy ‘Vital’ To Haiti An Economist editorial examines the relief and recovery efforts in Haiti and theÂ “vital” importance of planning for rebuilding the country “before the worldâ€™s generosity turns to cynicism. Fortunately there is a blueprint, drawn up by Haitiâ€™s government and presented to donors last year. It…
Though H1N1 (swine flu) activity worldwide has slowed, the potential of a new wave of infections in the northern hemisphere in late winter or early spring remains viable, Keiji Fukuda, the WHO’s top flu expert, said Monday at the start of the WHO’s weeklong Executive Board meeting, Reuters reports. The H1N1 pandemic “initially sparked widespread concern about antiviral and vaccine supplies, especially in developing countries, but many nations have cut back their vaccine orders recently because the pandemic has not turned out as deadly as originally feared,” the news service writes (Nebehay, 1/18).
Lancet Series Papers Examine Surveillance, Economic Impact Of NTDs “As national programmes respond to the new opportunities presented for scaling up preventive chemotherapy programmes for the coadministration of drugs to target [several neglected tropical diseases (NTDs)] possible synergies between existing disease-specific policies and protocols need to be examined,” write the…
Keiji Fukuda, the special adviser to the WHO director general on pandemic influenza, on Thursday dismissed allegations that the agency exaggerated the threat of the H1N1 (swine flu) pandemic and has been influenced by the pharmaceutical industry, the Washington Post reports. Fukuda’s defense came amid reports this week that the Council of Europe will investigate the WHO’s actions and as several countries slash H1N1 vaccine orders.
Amid recent complaints that the WHO exaggerated the threat of the H1N1 (swine flu) virus, the agency announced Tuesday an upcoming independent review of the agency’s handling of the pandemic, Agence France-Presse reports (1/12).
Media Outlets Examine U.S. Plans For Leftover H1N1 Vaccine, Efforts To Keep Flu Vaccine Production On Track
After working to ensure the U.S. had access to enough H1N1 (swine flu) vaccine, health officials may now face a new dilemma â€“ a vaccine surplus, the Associated Press reports. “Get ready for a huge flu-shot push as health officials try to rekindle interest in protection against this new influenza strain that, despite plummeting cases, still is threatening lives â€“ even as they reassess just how much more vaccine needs to be shipped,” the news service writes.
H1N1 (swine flu) has killed 12,799 people worldwide since the virus first emerged, the WHO said on Friday, United Press International reports (1/8). According to the WHO, more than half of the H1N1-related deaths worldwide occurred in the Americas, China Daily reports (1/9).